Sun Pharma’s arm recalls 3263 bottles of epilepsy drug in US

24 Feb 2015 Evaluate

Sun Pharmaceutical Industries is voluntarily recalling 3,263 bottles of Levetiracetam, extended release tablets, an anti epileptic drug, in the US market. Sun Pharma Global Fze, a US-based unit of the company, is recalling the drug for failing dissolution specifications. The 750 mg tablets in 60-count bottles, were manufactured by Sun Pharmaceutical Industries at Halol.

It has been classified as a 'Class-II recall' which FDA defined as 'a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.

Sun Pharmaceutical Industries is an international, integrated, specialty pharmaceutical company. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India, US and several other markets across the world.

Sun Pharma Inds. Share Price

1804.95 -13.65 (-0.75%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×